35086-8

LOINC 2.82

Second trimester triple maternal screen panel - Serum or Plasma

2nd trimester 3 screen Pnl SerPl

Definition

  • Triple marker screening is performed at 16-18 weeks' gestation for determining fetal anomalities including Trisomy 18, Trisomy 21 (Down's syndrome) and Neural Tube Defects (NTD).

Component

  • Second trimester triple maternal screen panel

Specimen / system

  • Ser/Plas

Class

  • PANEL.CHEM

Property

  • -

Scale

  • -

Related names

  • 2nd; 2nd trimester 3 screen; 2nd trimester 3 screen Pnl; AFP X-tra; Alpha-1-fetoprotein & Choriogonadotropin & Estriol.unconjugated; Chemistry; Gestation; Maternal screen 3; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Prenatal; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri; Trip; Triple marker screen

Index terms

  • 2nd
  • 2nd trimester 3 screen
  • 2nd trimester 3 screen Pnl
  • AFP X-tra
  • Alpha-1-fetoprotein & Choriogonadotropin & Estriol.unconjugated
  • Chemistry
  • Gestation
  • Maternal screen 3
  • Pan
  • PANEL.CHEMISTRY
  • Panl
  • Pl
  • Plasma
  • Plsm
  • Pnl
  • Point in time
  • Prenatal
  • Random
  • Scn
  • Scr
  • Scrn
  • SerP
  • SerPl
  • SerPlas
  • Serum
  • Serum or plasma
  • SR
  • Tri
  • Trip
  • Triple marker screen